Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Itaconix
Hampton, New Hampshire, USA
- Ownership
- Private
- Employees
- ~21
- Development stage
- Other
01
Overview
The latest clinical result field is "not applicable"; Itaconix develops commercial, plant-based polymers for safer, sustainable replacements of petrochemical ingredients in consumer/industrial products, with active market growth and successful launches (e.g., BIO*Asterix® specialty monomers)
- Modalities
- Polymer-drug conjugate therapy (for encapsulation)Polymer (itaconic acid-based)Specialty plant-based polymers
- Industry
- Non-Drug Biotech
02
Partnerships
Croda Inc.Nouryoncategory leaders in consumer brandsSolvayAkzoNobel
Beyond the preview
Go deeper on Itaconix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Itaconix.